Pavel Zak

Sokolska Street 581
Hradec Kralove, KR 50005, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 126 publications

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".

Erratum to: "Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial".

Journal: Haematologica

Published: April 01, 2026

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT.

Journal: Bone marrow transplantation

Published: December 25, 2025

How hematology has developed and where it is headed in Hradec Králové.

How hematology has developed and where it is headed in Hradec Králové.

Journal: Casopis lekaru ceskych

Published: November 13, 2025

Which myelofibrosis patients benefit from treatment with ruxolitinib? A single-center experience.

Which myelofibrosis patients benefit from treatment with ruxolitinib? A single-center experience.

Journal: Archives of medical science : AMS

Published: June 28, 2025

Population Pharmacokinetic Model-Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram-Positive Sepsis.

Population Pharmacokinetic Model-Based Optimization of Linezolid Dosing in Hematooncological Patients With Suspected or Proven Gram-Positive Sepsis.

Journal: Clinical and translational science

Published: May 06, 2025

Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Gemtuzumab ozogamicin in first-line treatment of CBF-AML: insights from a retrospective multi-center analysis.

Journal: Leukemia

Published: April 03, 2025

Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party.

Improved GVHD-free relapse-free survival when rATG/ATLG is used in allo-HCT from matched sibling donors - an EBMT registry study by the Transplant Complications Working Party.

Journal: Bone marrow transplantation

Published: March 14, 2025

FLT3-ITD measurable residual disease from the QuANTUM-First trial.

FLT3-ITD measurable residual disease from the QuANTUM-First trial.

Journal: Blood advances

Published: March 10, 2025

FLT3-ITD measurable residual disease from the QuANTUM-First trial.

FLT3-ITD measurable residual disease from the QuANTUM-First trial.

Journal: Blood advances

Published: March 10, 2025

Intensive Care Infection Score (ICIS) is an Early Marker for Infection in Time of Admission to Intensive Care Units.

Intensive Care Infection Score (ICIS) is an Early Marker for Infection in Time of Admission to Intensive Care Units.

Journal: International journal of laboratory hematology

Published: December 12, 2024

Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Clinical and Prognostic Significance of Additional Chromosomal Abnormalities at Diagnosis of Chronic Myeloid Leukemia.

Journal: American journal of hematology

Published: October 29, 2024

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report.

Journal: American journal of hematology

Published: October 16, 2024

Showing 1-12 of 126

Last Updated: 09/26/2026